Given the essentiality of cytoskeletal proteins in cancer cell migration, a therapeutic attempt to inhibit metastasis by targeting cytoskeletal proteins has shown promise, shedding light on this approach [6, 7]. This evidence concerns the gene DNM2 and cancer.